INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 157 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,000 | -88.9% | 64 | -88.8% | 0.00% | -100.0% |
| Q4 2021 | $9,000 | 0.0% | 571 | -1.4% | 0.00% | 0.0% |
| Q3 2021 | $9,000 | – | 579 | +6333.3% | 0.00% | – |
| Q1 2021 | $0 | – | 9 | -40.0% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 15 | -94.6% | 0.00% | -100.0% |
| Q2 2019 | $22,000 | +450.0% | 279 | +534.1% | 0.00% | +50.0% |
| Q1 2017 | $4,000 | -81.0% | 44 | -77.6% | 0.00% | -81.8% |
| Q4 2016 | $21,000 | -44.7% | 196 | -18.3% | 0.01% | -56.0% |
| Q3 2016 | $38,000 | +660.0% | 240 | +471.4% | 0.02% | +733.3% |
| Q2 2016 | $5,000 | -37.5% | 42 | -30.0% | 0.00% | -50.0% |
| Q4 2015 | $8,000 | – | 60 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |